Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 10 pseudogene 1 (PHF10P1; also known as XAP135P) is annotated as a pseudogene in the human genome and is not believed to produce a functional protein[1][3][5]. The gene is considered an inactive genomic element related to the PHD finger protein 10 (PHF10) gene. While PHF10 is a functional protein involved in chromatin remodeling and transcriptional regulation, PHF10P1 does not have any documented biological activity and is not considered a therapeutic target. No drugs are known to interact with PHF10P1, and it is not directly implicated in any disease, biological function, or molecular pathway. PHF10P1 is a pseudogene and not a protein-coding gene or a validated therapeutic target. Most research and therapeutic interest concerns PHF10, the functional gene/protein, not PHF10P1. Therefore, seeking PHF10P1 as a drug target or biomarker is incorrect; refer to PHF10 for functional studies[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 10 pseudogene 1 (PHF10P1).